Portfolio Company · Operating Co.
Company Snapshot
Onco Response is a portfolio company held by Bering Capital. Profile compiled from public sources; submit updates to extend the public record.
Ownership Context
Onco Response is a current portfolio company of Bering Capital. Public coverage of this company is grouped under its parent firm's profile.
Sources
https://beringcapital.com/companiesThis profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Onco Response and does not provide investment advice.
Other portfolio companies of Bering Capital
Atea Pharmaceuticals
Calcimedica
Cellworks
Coherus BioSciences
Coherus Oncology
Dragon Vascular
Fusion Medical
Invuity
See the full Bering Capital portfolio.